Study on the Clinical Profile of Dry Eye following Topical Phacoemulsification
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- dryness evaluation by tear film break up time, visual acuity, dryness evaluation by Schirmers test, dryness evaluation by tear meniscus height, ocular surface disease index questionnaire for evaluating symptoms of dryness.
Study Overview
Brief Summary
The purpose of a study on the clinical profile of dry eye following topical phacoemulsification is likely to investigate the prevalence, severity, and characteristics of dry eye syndrome in patients who have undergone topical phacoemulsification surgery for cataracts. This research aims to understand the impact of the topical phacoemulsification surgery on tear film stability, ocular surface health, and symptoms of dry eye, as well as to identify potential risk factors or predictive markers for postoperative dry eye. Additionally, such a study may explore interventions or strategies to mitigate dry eye symptoms and improve patient outcomes following cataract surgery.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 40.00 Year(s) to 70.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Patients who will present with senile cataracts during the study period but also have no history of dry eye syndrome 2.Patients giving their consent for the study.
Exclusion Criteria
- •1.Patients with prior systemic diseases or syndromes associated with dry eye (example: diabetes mellitus, hypertension, deficiency of Vitamin A, diseases related to thyroid) 2.Patients who are on medications which have an additional side effect of causing ocular dryness (eg: diuretics, psychotropic’s, antihistaminic, antidepressants, decongestants, beta blocker drugs, diuretics, and aspirin)(6) 3.Patients who wear contact lens 4.patients with various adnexal disorders, anterior or posterior segment disorders that affect the stability and secretion of tears, patients on topical antiglaucoma medications that leads to ocular drying 5.conjunctivitis Which is chronic in nature 6.patients having small pupil or pupil which is difficult to dilate.
Outcomes
Primary Outcomes
dryness evaluation by tear film break up time, visual acuity, dryness evaluation by Schirmers test, dryness evaluation by tear meniscus height, ocular surface disease index questionnaire for evaluating symptoms of dryness.
Time Frame: day 1, day 7 and day 30
Secondary Outcomes
- 1. dry eye(2. post operative inflammation)
Investigators
Diksha Garg
Datta Meghe Institute of Higher Education and Research